This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log in
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Apr 27:2:123.
doi: 10.1186/1752-1947年2月12日3.

Successful treatment of Mycobacterium ulcerans osteomyelitis with minor surgical debridement and prolonged rifampicin and ciprofloxacin therapy: a case report

Affiliations

Successful treatment of Mycobacterium ulcerans osteomyelitis with minor surgical debridement and prolonged rifampicin and ciprofloxacin therapy: a case report

Daniel P O'Brien et al. J Med Case Rep. .

Abstract

Introduction: Treatment for osteomyelitis-complicating Mycobacterium ulcerans infection typically requires extensive surgery and even amputation, with no reported benefit from adjunctive antibiotics.

Case presentation: We report a case of an 87-year-old woman with M. ulcerans osteomyelitis that resolved following limited surgical debridement and 6 months of therapy with rifampicin and ciprofloxacin.

Conclusion: M. ulcerans osteomyelitis can be successfully treated with limited surgical debridement and adjunctive oral antibiotics.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A magnetic resonance imaging scan of the foot showing the destructive changes of osteomyelitis in the proximal first metatarsal bone and adjacent medial cuneiform bone.

References

    1. Portaels F, Aguiar J, Debacker M, Guedenon A, Steunou C, Zinsou C, Meyers WM. Mycobacterium bovis BCG vaccination as prophylaxis against Mycobacterium ulcerans osteomyelitis in Buruli ulcer disease. Infect Immun. 2004;72:62–65. doi: 10.1128/IAI.72.1.62-65.2004. - DOI - PMC - PubMed
    1. Etuaful SC, Carbonnelle B, Grosset J, Lucas S, Horsefield C, Phillips R, Evans M, Ofori-Adjei D, Klustse E, Owusu-Boateng J, Amedofu GK, Awuah P, Ampadu E, Amofah G, Asiedu K, Wansbrough-Jones M. Bactericidal activity of rifampicin and streptomycin treatment for early human M. ulcerans lesions. Report of the Sixth WHO Advisory Group Meeting on Buruli Ulcer: Geneva, Switzerland. 2003. pp. 101–102.
    1. O'Brien DP, Hughes AJ, Cheng AC, Henry MJ, Callan P, McDonald A, Holten I, Birrell M, Sowerby JM, Johnson PD, Athan E. Improved outcomes for Mycobacterium ulcerans infection with combined surgery and antibiotic therapy: findings from a south-eastern Australian case series. Med J Aust. 2007;186:58–61. - PubMed
    1. Ross BC, Marino L, Oppedisano F, Edwards R, Roibbins-Browne RM, Jounson PD. Development of a PCR assay for rapid diagnosis of Mycobacterium ulcerans infection. J Clin Microbiol. 1997;35:1696–1700. - PMC - PubMed
    1. Hofer M, Hirschel B, Kirschner P, Beghetti M, Kaelin A, Siegrist CA, Suter S, Teske A, Bottger EC. Brief report: disseminated osteomyelitis from Mycobacterium ulcerans after a snakebite. N Engl J Med. 1993;328:1007–1009. doi: 10.1056/NEJM199304083281405. - DOI - PubMed

LinkOut - more resources

Cite

AltStyle によって変換されたページ (->オリジナル) /